Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
Where is the Front Door to the NHS?
How do we procure innovation and innovate procurement in Health?
What does health want?
How does an SME leverage Local Infrastructure
Presentation by Julie Collins, Apsiz Services at the Healthcare Business Connect Lancashire SME workshop - Bids and tenders at Society1, Preston on Thursday 22 November 2018.
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
Where is the Front Door to the NHS?
How do we procure innovation and innovate procurement in Health?
What does health want?
How does an SME leverage Local Infrastructure
Presentation by Julie Collins, Apsiz Services at the Healthcare Business Connect Lancashire SME workshop - Bids and tenders at Society1, Preston on Thursday 22 November 2018.
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
New Funding & Development Opportunities for InnovatorsIsabelle Sparrow
On November 8th GM AHSN invited innovators from the region to an event at the Nowgen Centre in Manchester. The event provided information about some of the current funding and support opportunities available to healthcare innovators, including programmes from GM AHSN's Innovation Nexus, SBRI Healthcare and the Business Growth Hub.
How do uk med tech startups cope with the capital pressureRina Nir
This was presented at the UK MedTec 2014 event by Dr. Dror Nir, managing partner in RadBee.
Dror analyses the financial eco-system of the UK MedTech segment based on data that was published in reports by the department of Business Innovations and Skills (BIS) in 2013, E&Y and KPMG. The bottom-line outcome of his analysis is that the majority of UK MedTech companies, particularly the startups, are straggling to survive with very little opportunities to carry on innovations.
New approach for sustaining long-term innovation is suggested.
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
Bits of Health programme´s vision is that Finland will be a leading digital health ecosystem giving birth to growth companies with succesfull international business.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Strategic purchasing: a comparative assessment of Civil Servant Medical Benef...resyst
This presentation was given at the International Health Economics Association (iHEA) World Congress in Milan, in July 2015. It includes results and policy implications from the RESYST Purchasing Study conducted in Thailand
Cogora in collaboration with NHS England conducted a series of in-depth interviews with the managing directors of 17 commissioning support units (CSUs) and the health leads at 23 independent sector providers of commissioning support services (CSSs).
Rachael Colley - Transformation of Procurement in the Changing NHS Landscape.Innovation Agency
Presentation by Rachael Colley, Head of Procurement Solutions and Innovation, NHS Shared Business Services on The Transformation of Procurement in the Changing NHS Landscape on Thursday 20 September at Northwich Memorial Court.
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
New Funding & Development Opportunities for InnovatorsIsabelle Sparrow
On November 8th GM AHSN invited innovators from the region to an event at the Nowgen Centre in Manchester. The event provided information about some of the current funding and support opportunities available to healthcare innovators, including programmes from GM AHSN's Innovation Nexus, SBRI Healthcare and the Business Growth Hub.
How do uk med tech startups cope with the capital pressureRina Nir
This was presented at the UK MedTec 2014 event by Dr. Dror Nir, managing partner in RadBee.
Dror analyses the financial eco-system of the UK MedTech segment based on data that was published in reports by the department of Business Innovations and Skills (BIS) in 2013, E&Y and KPMG. The bottom-line outcome of his analysis is that the majority of UK MedTech companies, particularly the startups, are straggling to survive with very little opportunities to carry on innovations.
New approach for sustaining long-term innovation is suggested.
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
Bits of Health programme´s vision is that Finland will be a leading digital health ecosystem giving birth to growth companies with succesfull international business.
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Strategic purchasing: a comparative assessment of Civil Servant Medical Benef...resyst
This presentation was given at the International Health Economics Association (iHEA) World Congress in Milan, in July 2015. It includes results and policy implications from the RESYST Purchasing Study conducted in Thailand
Cogora in collaboration with NHS England conducted a series of in-depth interviews with the managing directors of 17 commissioning support units (CSUs) and the health leads at 23 independent sector providers of commissioning support services (CSSs).
Rachael Colley - Transformation of Procurement in the Changing NHS Landscape.Innovation Agency
Presentation by Rachael Colley, Head of Procurement Solutions and Innovation, NHS Shared Business Services on The Transformation of Procurement in the Changing NHS Landscape on Thursday 20 September at Northwich Memorial Court.
Dr Liz Mear, Chief Executive of the Innovation Agency presented at NHS Confed 17 about the NHS’ role in growing local economies and how Academic Health and Science Networks (AHSNs) can generate economic growth in life sciences through their role as catalysts, connectors and collaborators by spreading innovation, advancing health technology and improving healthcare
Optimising your Practice - a toolkit to survive a changing NHS environmentOneMedicalGroup
Slides presented at the recent education seminar held at the King's Fund, London on 9 October 2014.
This event was hosted by OneMedicalGroup, a nationally recognised and award winning provider of bespoke premises solutions and patient focussed care.
For more information please see:
www.onemedicalgroup.co.uk
Presented by Lee Whitehead, Business Developer, 3SC at NCVO's Evolve Conference 2015.
The advantages and disadvantages of acting as a prime and contractor in the supply chain, as well as some of the risks involved.
Is subcontracting right for your organisation?
https://www.ncvo.org.uk/training-and-events/evolve-conference
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
Presentation by Karen Livingstone, Director of Innovation Exchange and SBRI Healthcare, NHS England: Transforming Health and Social Care Services - The Innovation Exchange and SBRI Healthcare at ECO 17: Transforming care through digital health on Tuesday 4 December at Lancaster University, Lancaster
Industrial Strategy:Prospering from the energy revolution - Rob Saunders, In...KTN
Key technology components for local energy systems
briefing event
The webcast recording is now available. Click here to watch it: https://www.youtube.com/watch?v=gPyTb_-qhgo
Find out more about Energy interest group at https://ktn-uk.co.uk/interests/energy
Join the Energy LinkedIn group at https://www.linkedin.com/groups/3380615/
Midlands and East GP Forward View access update event July 2017NHS England
A presentation from the GP Forward View update event in July 2017 for Midlands and East, giving the latest information on improved access to primary care.
Similar to Lancashire Health Matters: networking and knowledge event (20)
Presentations by Tawfiq Choudhury and Rocco Hadland from the second webinar of the Mastering Cholesterol webinar series on Thursday 11 May 2023, focusing on Statins.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
2. We are the Academic Health Science Network for the North
West Coast - one of 15 in England.
The focus of the AHSN is supporting the adoption and
spread of innovation to improve care and services in the
NHS and social care
– pathways, protocols, policies, practice or products.
We do that by connecting our networks of partners across
all sectors: NHS, Universities, LA, the third sector and
businesses.
3. The focus of LHMs is to accelerate the adoption and spread
of products and services that already exist to help the NHS
to improve its care and services to patients.
The offer is:
• Introductions to senior NHS staff
• Product positioning and value proposition
• Understanding the NHS landscape
• Procurement and commissioning
• Business case development
• Real-world validation
• Pitching and presenting
• Funding
Our USP is our
extensive NHS
knowledge and
networks
7. LSC Health and Care Partnership
• 1.8M population
• 11 CCG
• 5 NHS hospitals(Trusts)
• 500 GP practices
• 44 PCNs
8.
9. The NHS mantra
Procurement seen as
key solution to these
problems
● More with less
● Reduce variation
● Increase efficiency
● Reduce cost without clinical
compromise
Repeat…
10. NHS Procurement: Lancs & South Cumbria
Lancashire Procurement Cluster
Blackpool Teaching Hospitals
East Lancashire Teaching Hospitals
Lancashire Teaching Hospitals
University Hospitals of Morecambe Bay
North Cumbria Integrated Care NHS FT
Lancashire & South Cumbria FT
● Strong focus on compliance and delivery of cashable savings
● All teams very successful in terms of delivering savings
● Tactical unit price initiatives
● Strategic efficiency schemes, market management, process improvement, focussing on the
value chain.
● Collaboration at scale
National Procurement Target Operating Model
– PTOM “System by Default”
11. The NHS as an anchor institution
Time for a Paradigm
shift
“There is a social gradient in
lifespan; people living in the
most deprived areas in England
have on average the lowest life
expectancy and conversely, life
expectancy is higher on average
for those living in areas with
lower deprivation.”
• Influencible spend
L&SC is circa £300 m
• What proportion is going into
the local economy?
• How are we incentivising
suppliers to improve health and
economic outcomes for our
communities?
• How are we incentivising
suppliers to improve the
environmental impact of their
activities?
12. LPC performance framework
Measurable Key Performance Indicators
• Increasing local & SME spend
• NHS Zero Carbon metrics
• Promoting best employment
practices
• More diverse supplier groups
13. NHS Supply Chain
The new NHS Supply Chain was designed to help the NHS deliver clinically assured,
quality products at the best value, through a range of specialist buying functions.
● Aims to deliver savings of £2.4bn back into NHS frontline services by 2023.
● The new model consists of eleven specialist buying functions, known as Category
Towers
● Three enabling services for logistics, supporting technology and transactional services
underpin the model.
Key benefits:
Suppliers
• Lowering sales and marketing costs
• Single route into the national market
• A joined-up approach across the NHS
• Clear route for innovative products
NHS Trusts
• Savings channelled back to frontline services
• Releasing more time for core clinical activities
• Greater NHS clinical involvement in
purchasing decision
• More effective introduction of new products
14. Procurement Towers
There are 11 specialist buying functions knowns as category towers….
Non Medical
Tower 11
NHS Hotel Services
Tower 4
Orthopaedics, Trauma &
Spine, Ophthalmology
Medical
Tower 3
Infection Control
And Wound Care
Tower 5
Rehabilitation, Disable
Services, Women’s
Health & Associated
Consumables
Tower 2
Sterile Intervention
Equipment And
Associated
Consumables Tower 10
Food
Tower 9
Office Environment
Capital
Tower 7
Large Diagnostic
Capital Devices incl.
Mobile &
Consumables
Tower 8
Diagnostic
Equipment and
Associated
Consumables
Tower 1
Ward Based
Consumables
Tower 6
Cardio-Vascular,
Radiology, Audiology &
Pain Management
15. Opportunities:
If yes…
● Register on procurement towers
framework - suppliers@supplychain.nhs.uk
● Consider partnering with a larger supplier
● Consider forming a consortia
● Use your AHSN as conduit
16. What is a Framework Agreement?
Definition: an agreement between a Contracting Authority (e.g. NHS SBS,
an NHS Trust, or a local council) and one or more suppliers, the purpose of
which is to establish the terms governing contracts to be awarded during a
given period, in particular with regard to price and, where appropriate, the
quantity.
● 6-9 month procurement process
● Awarded following a fully OJEU compliant process under the 2015 Public Contracts
Regulations
● Usually awarded for a period of 4 years
● *Legal requirement for public sector procurements over the value
of £118K
● Approx. cost of £25,000 per tender process for a Contracting Authority
17. Health system support framework
What is is?: a quick and easy route to access support services from
innovative third party suppliers at the leading edge of health and care system
reform.
● Can be used by any NHS organisation, including NHS Trusts, Clinical Commissioning
Groups (CCGs), national Arm’s-Length Bodies and local authorities
● Integrated Care Systems (ICSs) and Sustainability and Transformation
Partnerships (STPs) can use the HSS to access innovative technologies and digital
vendors to drive forward system reform
● The Framework focuses particularly on services that can support the move to
integrated models of care based on intelligence-led population health management
18. Framework areas
● Infrastructure:
o Electronic Patient Records and place-based digitalisation
o local health and care records across different care settings
o primary care IT support and cyber security
● Intelligence:
o targeted population health analytics
o digital tools for system modelling, actuarial assessment, planning, research, risk
stratification and impactability modelling
o clinical decision support tools
● Impact and Intervention:
o transformation and change support
o patient empowerment and activation (including self-care support, personalisation, assistive
technologies and remote consultations)
o demand management and capacity planning support solutions
o system assurance and provider modernisation
o medicines management support
19. G-Cloud
What is it?: G-Cloud (RM1557ix) is a framework where supplier cloud-
based solutions are made available through a front-end Catalogue called the
Digital Marketplace.
o G-Cloud framework is THE place to be, for companies who are
thinking about selling their cloud-based solutions to the UK
government.
The Digital Marketplace is an online service for public sector organisations
to find people and technology for digital projects.
o Any public sector organisation, including agencies and arm's length
bodies, can buy using the Digital Marketplace.
20. Where to look for NHS opportunities
NHS Opportunities MUST be published online - you need to put the work in, you
have to search!
Essential Sites:
Above OJEU >£118k DoH, NHS Trusts / £181k NHS England, CCGs & NHS
Foundation Trusts
o TED Europa http://www.ted-Europa.eu
Below OJEU >£10k to £118k / £181k
o Contracts Finder http://online.contractsfinder.businesslink.gov.uk
Contracts Finder pulls from all sites where possible (One Place – Full
Transparency)
Other Useful Sites:
o Public Contracts Scotland – www.publiccontractsscotland.gov.uk
o Sell2Wales – www.sell2wales.gov.uk
o eSourcing Northern Ireland – www.e-sourcingni.bravosolutions.co.uk
21. How to look for NHS opportunities
● Registering is essential
● Register for all or as many as possible
● Searching for Opportunities is critical
● CPV Codes, NUTS codes and / or Key Words
o CPV Codes – define what is being sourced (e.g. 3314000 Medical
Consumables)
o NUTS codes define the location (e.g. Essex – UKH3)
● Use Alerts
● Regularly review sites and evaluate opportunities
23. Framework and contracts database
Framework Database
To search by supplier, click on the arrow
below and enter the supplier name
To search by category or keyword,
click on the arrow below and enter
the keyword
Suppliers Organisation Framework No. Framework Name Start Date Expiry Date
Contact Framework Provider Crown Commercial Services RM6102 Apprenticeship Training Dynamic Marketplace DPS 30/04/2019 29/04/2023
ACTACCOMLIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
ACTAVO BUILDING SOLUTIONS (UK) LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
ASHBY & CROFT LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
CALEDONIAN MODULAR LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
DARWIN GROUP LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
ECO MODULAR BUILDINGS LTD Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
ELITE SYSTEMS (GB) LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
ELLIOTT GROUP LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
EXTRASPACE SOLUTIONS (UK) LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
IDEAL BUILDING SYSTEMS LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
INTEGRA BUILDINGS LIMITED Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
MCAVOY GROUP LIMITED - THE Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
M-AR Off-site Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
Cotaplan (Modular Buildings) Crown Commercial Services RM6014 Modular Building Solutions 02/04/2019 01/04/2023
4NET TECHNOLOGIES LTD Crown Commercial Services RM3808 Network Services 2 12/08/2019 16/08/2022
8x8 Crown Commercial Services RM3808 Network Services 2 12/08/2019 16/08/2022
ABZORB GROUP LTD Crown Commercial Services RM3808 Network Services 2 12/08/2019 16/08/2022
ADEPT TECHNOLOGY GROUP PLC Crown Commercial Services RM3808 Network Services 2 12/08/2019 16/08/2022
Will be on LPC website shortly in public domain
• 16,000 suppliers
• 535 framework agreements/lots
• Covers main procurement partner organisation frameworks including: Crown Commercial Services,
Healthtrust Europe, NHS Supply Chain, North of England Commercial Procurement Collaborative, NHS
Shared Business Services
24. Find out more on NHS and LPC
procurement policy
Visit our website and use the following link: https://lancashireprocurement.nhs.uk/aim-values/lpc-procurement-policy
25. What does this mean for you?
● Providers procure products, Commissioners commission services
● Emerging Integrated Care Systems hold some funds but aren’t real
yet
● The organisation that uses a product may not be the organisation
that reaps the benefit
● Operational efficiencies vs cost savings
● 70% NHS costs are in staff. Incremental changes are not cash
releasing for commissioners
● What will your product replace or improve?
● The tariff for PbR is available publically. Use it.
https://improvement.nhs.uk/resources/national-tariff-1719/